Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial - Concepedia

Concepedia

Publication | Open Access

Effect of denosumab on bone mineral density and biochemical markers of bone turnover: 8-year results of a phase 2 clinical trial

DOI Full Paper Access

113

Citations

24

References

2012

Year

Michael R. McClung, E. Michael Lewiecki, Michelle Geller, Michael A. Bolognese, Munro Peacock, Richard L. Weinstein, Beiying Ding, Erica Rockabrand, Rachel B. Wagman, Paul D. Miller

Osteoporosis International

Abstract

Continued denosumab treatment for 8 years was associated with progressive gains in BMD, persistent reductions in BTM, and was well tolerated.

References

	Year	Citations

Page 1